Table I.
IL-6 & FeNO | LL (278)* | LH (249)* | HL (88)* | HH (90)* | Four Groups | |||||
n | mean ± SD | n | mean ± SD | n | mean ± SD | n | mean ± SD | P value† | P value‡ (Adjusted) | |
Body mass index (BMI) | 278 | 31 ± 6.9 | 249 | 29 ± 6.9 | 88 | 39 ± 12 | 90 | 35 ± 9.0 | <0.0001 | NA |
Baseline FEV1 % predicted | 278 | 77 ± 21 | 249 | 76 ± 19 | 88 | 70 ± 21 | 90 | 70 ± 19 | 0.001 | 0.014 |
Blood neutrophil counts (cells/μl) | 273 | 3974 ±1625 | 247 | 3822 ± 1562 | 86 | 5576 ± 2407 | 87 | 5379 ± 3133 | <0.0001 | <0.0001 |
Blood eosinophil counts (cells/μl) | 273 | 201 ± 158 | 245 | 339 ± 286 | 85 | 223 ± 262 | 86 | 345 ± 270 | <0.0001 | <0.0001 |
FeNO (ppb) | 278 | 14 ± 5.4 | 249 | 58± 41 | 88 | 15 ± 5.7 | 90 | 49 ± 35 | <0.0001 | <0.0001 |
Systemic corticosteroid use in last year (% yes) | 278 | 28 | 249 | 27 | 88 | 45 | 90 | 50 | <0.0001 | 0.0048 |
% ΔFEV1 (corticosteroid evoked) in SARP3 | 145 | 2.6 ± 13 | 107 | 6.8 ± 16 | 48 | 1.4 ± 15 | 40 | 8.8 ± 18 | 0.0007 | 0.039 |
IL-6 & Blood eosinophil count | LL (344)** | LH (216)** | HL (113)** | HH (65)** | Four Groups | |||||
n | mean ± SD | n | mean ± SD | n | mean ± SD | n | mean ± SD | P value† | P value‡ (Adjusted) | |
Body mass index (BMI) | 344 | 30 ± 7.0 | 215 | 30 ± 7.1 | 113 | 38 ± 11 | 65 | 35 ± 9.3 | <0.0001 | NA |
Baseline FEV1 % predicted | 344 | 78 ± 20 | 215 | 73 ± 19 | 113 | 71 ± 19 | 65 | 68 ± 20 | <0.0001 | 0.0033 |
Blood neutrophil counts (cells/μl) | 344 | 3818 ± 1694 | 216 | 4003 ± 1459 | 113 | 5320 ± 2800 | 65 | 5578 ± 2631 | <0.0001 | <0.0001 |
Blood eosinophil counts (cells/μl) | 344 | 136 ± 70 | 216 | 480 ± 262 | 113 | 141 ± 80 | 65 | 524 ± 305 | <0.0001 | <0.0001 |
FeNO (ppb) | 327 | 28 ± 29 | 197 | 47 ± 44 | 108 | 27 ± 23 | 63 | 41 ± 38 | <0.0001 | <0.0001 |
Systemic corticosteroid use in last year (% yes) | 344 | 25 | 215 | 29 | 113 | 44 | 65 | 54 | <0.0001 | 0.002 |
% ΔFEV1 (corticosteroid evoked) in SARP3 | 164 | 3.3 ± 13 | 92 | 6.2 ± 17 | 55 | 0.4 ± 11 | 33 | 12 ± 21 | 0.008 | 0.004 |
LL: low IL-6 and low FeNO, LH: low IL-6 and high FeNO, HL: high IL-6 and low FeNO, HH: high IL-6 and high FeNO
Kruskal-Wallis test
Generalized linear model adjusted for age, sex, BMI, and race
LL: low IL-6 and low blood eosinophil count, LH: low IL-6 and high blood eosinophil count, HL: high IL-6 and low blood eosinophil count, HH: high IL-6 and high blood eosinophil count. This is a partial table for combination of IL-6 and FeNO levels or IL-6 and blood eosinophil count. Please refer to Table E9 and Table E12 for complete phenotypes tested.